• HOME

• ABOUT

• PANCREATIC CANCER

• TECHNOLOGY

• NEWS & MEDIA

For Patients & Caregivers

The team at ACT is acutely aware of the huge need for new therapies and hope for all cancer patients, and specifically pancreatic cancer patients. We are actively working on getting our drug delivery system to patients as quickly as possible. We have recently received great news that we will have the funding to bring our technology to a safety trial in 2023. We are continuing to work hard to get funding to bring our technology into more extensive clinical trials after that.

Until we are ready to begin enrolling in these trials, we encourage you to visit the PanCan Clinical Trial Finder to locate the most appropriate trials that are currently enrolling patients.